Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001553350-26-000111

Chief Medical Officer sold 23,452 shares at an average $6.41 ($150,340)

  • Chief Medical Officer acquired 23,452 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Podnos Yale · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-14 Exercise or conversion : show line 1 in the form 10b5-1 +17,974 $1.87 $33,611 277,501 D
2026-07-14 Sale : show line 2 in the form 10b5-1 −17,974 $6.43 $115,555 259,527 D
2026-07-14 Exercise or conversion : show line 3 in the form 10b5-1 +5,478 $2.00 $10,956 265,005 D
2026-07-14 Sale : show line 4 in the form 10b5-1 −5,478 $6.35 $34,785 259,527 D
Open-market sales · 23,452 sh · avg $6.41 · $150,340

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-14 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) +17,974 $1.87 $33,611 0 D
2026-07-14 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) +5,478 $2.00 $10,956 0 D
Loading xslF345X06/ownership.xml…